Yoko Kubuki Selected Research

Leukemic Infiltration

1/2006	Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
5/2003	Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoko Kubuki Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 12/2002
12	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2021 - 07/2004
4	Splenomegaly 01/2021 - 10/2015
3	Leukemia 01/2020 - 01/2006
3	Thrombosis (Thrombus) 01/2019 - 04/2010
2	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 01/2019
2	Anemia 01/2021 - 10/2018
2	Leukocytosis (Pleocytosis) 10/2018 - 01/2017
2	Leukemic Infiltration 01/2006 - 05/2003
2	T-Cell Leukemia (Leukemia, T Cell) 01/2006 - 05/2003
1	Infections 09/2021
1	Disease Progression 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Essential Thrombocythemia 01/2019
1	Headache (Headaches) 12/2017
1	Hepatitis C 12/2017
1	Pruritus (Itching) 12/2017
1	Constipation 12/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2017
1	Iron Deficiencies 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Nasopharyngeal Carcinoma 01/2015
1	Acute Promyelocytic Leukemia 09/2012
1	Hematologic Diseases (Blood Diseases) 09/2012
1	Thrombotic Thrombocytopenic Purpura 04/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2006
1	HTLV-I Infections (HTLV-I Infection) 01/2006
1	Carcinogenesis 03/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2005
1	Lung Neoplasms (Lung Cancer) 02/2005

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 09/2020 - 01/2017
2	Immunoglobulin G (IgG)IBA 09/2020 - 01/2017
2	Transferrin Receptors (Transferrin Receptor)IBA 09/2020 - 01/2017
2	CalreticulinIBA 01/2020 - 01/2019
2	AntibodiesIBA 01/2017 - 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Cell Adhesion Molecule-1IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	CytokinesIBA 01/2021
1	CollagenIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Biological ProductsIBA 01/2020
1	Troponin T (Troponin T1)IBA 01/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	IsoenzymesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2018
1	SofosbuvirIBA 12/2017
1	ledipasvirIBA 12/2017
1	mogamulizumabIBA 05/2017
1	Janus Kinase 2IBA 01/2017
1	IronIBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	Iron Regulatory Protein 2IBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	LigandsIBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2015
1	Janus Kinase InhibitorsIBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2010
1	Warfarin (Coumadin)FDA LinkGeneric 04/2010
1	thiamine triphosphorate (TTP)IBA 04/2010
1	Prednisolone (Predate)FDA LinkGeneric 04/2010
1	Complement System Proteins (Complement)IBA 11/2008
1	LectinsIBA 11/2008
1	HIV Protease InhibitorsIBA 01/2006
1	Ritonavir (Norvir)FDA Link 01/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2005
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 03/2005
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2005
1	Interleukin-2 (IL2)IBA 02/2005
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 02/2005
1	Cell Adhesion MoleculesIBA 02/2005
1	Caveolin 1IBA 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 07/2004
1	NF-kappa B (NF-kB)IBA 05/2003
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 05/2003
1	Aligeron (AS 2)IBA 05/2003
1	Gadolinium DTPA (Magnevist)FDA Link 12/2002

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 03/2021 - 01/2006
6	Therapeutics 12/2017 - 10/2015
1	Cell Transplantation 10/2018
1	Molecular Targeted Therapy 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2015
1	Chemoradiotherapy 01/2015